Arcadia Biosciences, Inc. (RKDA) Balance sheet

Market cap

$2.52M

P/E ratio

	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	24	2	9	12	8	14	29	21	7	4
Marketable securities, current	26	49	4	10	17	12	-	-	5	-
Total cash & short-term investments	50	51	13	22	25	26	29	21	12	4
Accounts receivable, net	1	0	1	0	1	1	1	-	-	-
Inventories	0	0	0	0	2	4	4	3	2	1
Total current assets	52	52	15	23	28	32	35	25	15	9
Property, plant and equipment, net	1	1	0	0	2	4	2	1	0	0
Marketable securities, non-current	20	2	-	-	-	-	-	-	-	-
Total non-current assets	22	4	2	1	4	16	9	4	5	4
Total assets	74	57	17	24	33	47	44	29	20	14
Total current liabilities	3	3	4	3	6	6	5	4	4	3
Long-term debt, non-current	-	-	-	-	-	2	-	-	-	-
Total non-current liabilities	31	31	5	8	19	12	8	4	3	5
Total liabilities	34	34	9	11	24	19	13	8	7	7
Common stock and paid-in capital	0	0	0	0	0	0	0	0	0	0
Retained earnings	-132	-152	-167	-178	-207	-212	-226	-258	-272	-279
Stockholders' equity	40	22	8	13	8	29	31	21	13	6
Total debt	-	-	-	-	-	2	-	-	-	-
Net debt	-	-	-	-	-	-24	-	-	-	-
D/E ratio (%)	-	-	-	-	-	7.4	-	-	-	-